193 related articles for article (PubMed ID: 24042270)
1. Synthesis and antitumor activity of a series of osmium(VI) nitrido complexes bearing quinolinolato ligands.
Tang Q; Ni WX; Leung CF; Man WL; Lau KK; Liang Y; Lam YW; Wong WY; Peng SM; Liu GJ; Lau TC
Chem Commun (Camb); 2013 Nov; 49(85):9980-2. PubMed ID: 24042270
[TBL] [Abstract][Full Text] [Related]
2. Osmium(VI) nitride triggers mitochondria-induced oncosis and apoptosis.
Ye M; Huang WQ; Li ZX; Wang CX; Liu T; Chen Y; Hor CH; Man WL; Ni WX
Chem Commun (Camb); 2022 Feb; 58(15):2468-2471. PubMed ID: 35024704
[TBL] [Abstract][Full Text] [Related]
3. A cytotoxic nitrido-osmium(VI) complex induces caspase-mediated apoptosis in HepG2 cancer cells.
Huang WQ; Wang CX; Liu T; Li ZX; Pan C; Chen YZ; Lian X; Man WL; Ni WX
Dalton Trans; 2020 Dec; 49(47):17173-17182. PubMed ID: 33119012
[TBL] [Abstract][Full Text] [Related]
4. Reactivity of nitrido complexes of ruthenium(VI), osmium(VI), and manganese(V) bearing Schiff base and simple anionic ligands.
Man WL; Lam WW; Lau TC
Acc Chem Res; 2014 Feb; 47(2):427-39. PubMed ID: 24047467
[TBL] [Abstract][Full Text] [Related]
5. Biological properties of novel ruthenium- and osmium-nitrosyl complexes with azole heterocycles.
Novak MS; Büchel GE; Keppler BK; Jakupec MA
J Biol Inorg Chem; 2016 Jun; 21(3):347-56. PubMed ID: 26961253
[TBL] [Abstract][Full Text] [Related]
6. Introducing the 4-Phenyl-1,2,3-Triazole Moiety as a Versatile Scaffold for the Development of Cytotoxic Ruthenium(II) and Osmium(II) Arene Cyclometalates.
Riedl CA; Flocke LS; Hejl M; Roller A; Klose MH; Jakupec MA; Kandioller W; Keppler BK
Inorg Chem; 2017 Jan; 56(1):528-541. PubMed ID: 27996251
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence, DNA Interaction and Cytotoxicity Studies of 4,5-Dihydro-1H-Pyrazol-1-Yl Moiety Based Os(IV) Compounds: Synthesis, Characterization and Biological Evaluation.
Pursuwani BH; Bhatt BS; Vaidya FU; Pathak C; Patel MN
J Fluoresc; 2021 Mar; 31(2):349-362. PubMed ID: 33389418
[TBL] [Abstract][Full Text] [Related]
8. Ruthenium(II) and osmium(II) 1,2,3-triazolylidene organometallics: a preliminary investigation into the biological activity of 'click' carbene complexes.
Kilpin KJ; Crot S; Riedel T; Kitchen JA; Dyson PJ
Dalton Trans; 2014 Jan; 43(3):1443-8. PubMed ID: 24201979
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, structure and anticancer properties of new biotin- and morpholine-functionalized ruthenium and osmium half-sandwich complexes.
Marloye M; Inam H; Moore CJ; Debaille V; Pritchard JR; Gelbcke M; Meyer F; Dufrasne F; Berger G
J Biol Inorg Chem; 2021 Aug; 26(5):535-549. PubMed ID: 34173882
[TBL] [Abstract][Full Text] [Related]
10. Photoactivated Osmium Arene Anticancer Complexes.
Xue X; Fu Y; He L; Salassa L; He LF; Hao YY; Koh MJ; Soulié C; Needham RJ; Habtemariam A; Garino C; Lomachenko KA; Su Z; Qian Y; Paterson MJ; Mao ZW; Liu HK; Sadler PJ
Inorg Chem; 2021 Dec; 60(23):17450-17461. PubMed ID: 34503331
[TBL] [Abstract][Full Text] [Related]
11. From hydrolytically labile to hydrolytically stable Ru(II)-arene anticancer complexes with carbohydrate-derived co-ligands.
Hanif M; Meier SM; Kandioller W; Bytzek A; Hejl M; Hartinger CG; Nazarov AA; Arion VB; Jakupec MA; Dyson PJ; Keppler BK
J Inorg Biochem; 2011 Feb; 105(2):224-31. PubMed ID: 21194622
[TBL] [Abstract][Full Text] [Related]
12. A breast cancer stem cell-selective, mammospheres-potent osmium(VI) nitrido complex.
Suntharalingam K; Lin W; Johnstone TC; Bruno PM; Zheng YR; Hemann MT; Lippard SJ
J Am Chem Soc; 2014 Oct; 136(41):14413-6. PubMed ID: 25247635
[TBL] [Abstract][Full Text] [Related]
13. Bidentate ligands on osmium(VI) nitrido complexes control intracellular targeting and cell death pathways.
Suntharalingam K; Johnstone TC; Bruno PM; Lin W; Hemann MT; Lippard SJ
J Am Chem Soc; 2013 Sep; 135(38):14060-3. PubMed ID: 24041161
[TBL] [Abstract][Full Text] [Related]
14. Future potential of osmium complexes as anticancer drug candidates, photosensitizers and organelle-targeted probes.
Zhang P; Huang H
Dalton Trans; 2018 Oct; 47(42):14841-14854. PubMed ID: 30325378
[TBL] [Abstract][Full Text] [Related]
15. Reduction Mechanisms of Anticancer Osmium(VI) Complexes Revealed by Atomic Telemetry and Theoretical Calculations.
Berger G; Wach A; Sá J; Szlachetko J
Inorg Chem; 2021 May; 60(9):6663-6671. PubMed ID: 33871984
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effects of a tetradentate amido-carboxylate ligands and corresponding square-planar palladium(II) complexes toward some cancer cells. Crystal structure, DFT modeling and ligand to DNA probe docking simulation.
Matović ZD; Mrkalić E; Bogdanović G; Kojić V; Meetsma A; Jelić R
J Inorg Biochem; 2013 Apr; 121():134-44. PubMed ID: 23376555
[TBL] [Abstract][Full Text] [Related]
17. Half-sandwich Os(ii) and Ru(ii) bathophenanthroline complexes: anticancer drug candidates with unusual potency and a cellular activity profile in highly invasive triple-negative breast cancer cells.
Pracharova J; Novohradsky V; Kostrhunova H; Štarha P; Trávníček Z; Kasparkova J; Brabec V
Dalton Trans; 2018 Sep; 47(35):12197-12208. PubMed ID: 30112527
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, structure and anti-cancer activity of osmium complexes bearing π-bound arene substituents and phosphane Co-Ligands: A review.
Nabiyeva T; Marschner C; Blom B
Eur J Med Chem; 2020 Sep; 201():112483. PubMed ID: 32592914
[TBL] [Abstract][Full Text] [Related]
19. Osmium(II)--versus ruthenium(II)--arene carbohydrate-based anticancer compounds: similarities and differences.
Hanif M; Nazarov AA; Hartinger CG; Kandioller W; Jakupec MA; Arion VB; Dyson PJ; Keppler BK
Dalton Trans; 2010 Aug; 39(31):7345-52. PubMed ID: 20601976
[TBL] [Abstract][Full Text] [Related]
20. Alkyl substituted 2'-benzoylpyridine thiosemicarbazone chelators with potent and selective anti-neoplastic activity: novel ligands that limit methemoglobin formation.
Stefani C; Jansson PJ; Gutierrez E; Bernhardt PV; Richardson DR; Kalinowski DS
J Med Chem; 2013 Jan; 56(1):357-70. PubMed ID: 23276209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
